Socio-economic inequalities in diabetes prevalence in the Kingdom of Saudi Arabia
Corresponding Author
Mohammed Khaled Al-Hanawi
Department of Health Services and Hospital Administration, Faculty of Economics and Administration, King Abdulaziz University, Jeddah, Saudi Arabia
Correspondence
Mohammed Khaled Al-Hanawi, Department of Health Services and Hospital Administration, Faculty of Economics and Administration, King Abdulaziz University, Jeddah, Saudi Arabia.
Email: [email protected]
Search for more papers by this authorGowokani Chijere Chirwa
Centre for Health Economics, University of York, York, United Kingdom
Department of Economics, University of Malawi, Chancellor College, Zomba, Malawi
Search for more papers by this authorMohammad Habibullah Pulok
Geriatric Medicine Research, Nova Scotia Health Authority and Dalhousie University, Halifax, Nova Scotia, Canada
Search for more papers by this authorCorresponding Author
Mohammed Khaled Al-Hanawi
Department of Health Services and Hospital Administration, Faculty of Economics and Administration, King Abdulaziz University, Jeddah, Saudi Arabia
Correspondence
Mohammed Khaled Al-Hanawi, Department of Health Services and Hospital Administration, Faculty of Economics and Administration, King Abdulaziz University, Jeddah, Saudi Arabia.
Email: [email protected]
Search for more papers by this authorGowokani Chijere Chirwa
Centre for Health Economics, University of York, York, United Kingdom
Department of Economics, University of Malawi, Chancellor College, Zomba, Malawi
Search for more papers by this authorMohammad Habibullah Pulok
Geriatric Medicine Research, Nova Scotia Health Authority and Dalhousie University, Halifax, Nova Scotia, Canada
Search for more papers by this authorFunding information: Deanship of Scientific Research (DSR), Grant/Award Number: PH-2-120-1440
Summary
Background
Rising prevalence of non-communicable diseases, including diabetes in the Middle East, is a major public health concern of the 21st century. However, there is a paucity of literature to understand and measure socio-economic inequalities in diabetes prevalence in this region, including the Kingdom of Saudi Arabia (KSA).
Methods
This study investigated socio-economic inequalities in diabetes prevalence in the KSA using data from the Saudi Arabia Health Interview Survey. Concentration curve, concentration index, and multivariate logistic regression were used to measure and examine income- and education-related inequalities in diabetes prevalence.
Results
The results showed significant socio-economic inequalities in the prevalence of diabetes through analysing a nationally representative sample of the KSA population. Diabetes prevalence was concentrated among the poor and among people with less education. In addition, education-related inequality was higher than income-related inequality.
Conclusions
The findings of this study are important for policymakers to combat both the increasing prevalence of and socio-economic inequalities in diabetes. The government should promote health education programmes and increase the level of public awareness of diabetes management, especially among the lower educated population in the KSA.
CONFLICT OF INTEREST
The authors declare that they have no conflicts of interest.
REFERENCES
- 1Al-Hanawi M, Alsharqi O, Almazrou S, Vaidya K. Healthcare finance in the Kingdom of Saudi Arabia: a qualitative study of householders' attitudes. Appl Health Econ Health Policy. 2018; 16(1): 55-64.
- 2Albejaidi FM. Healthcare system in Saudi Arabia: an analysis of structure, total quality management and future challenges. J Altern Perspect Soc Sci. 2010; 2(2): 794-818.
- 3Almalki M, FitzGerald G, Clark M. Health care system in Saudi Arabia: an overview. East Mediterr Health J. 2011; 17(10): 784-793.
- 4Al-Hanawi M, Alsharqi O, Vaidya K. Willingness to pay for improved public health care services in Saudi Arabia: a contingent valuation study among heads of Saudi households. Health Econ Policy Law. 2018; 1-28.
- 5Al-Hazzaa HM, Musaiger AO. Group ATLSR. Physical activity patterns and eating habits of adolescents living in major Arab cities. The Arab Teens Lifestyle Study. Saudi Med J. 2010; 31(2): 210-211.
- 6Khaliq AA. The Saudi health care system: a view from the minaret. World Health Popul. 2012; 13(3): 52-64.
- 7 WHO. Country cooperation strategy for WHO and Saudi Arabia 2012-2016. Regional Office for the Eastern Mediterranean, World Health Organization; 2013.
- 8 WHO. NCD Country Profiles 2018; https://www.who.int/nmh/countries/2018/sau_en.pdf?ua=1. Accessed 1 April, 2019.
- 9Alhyas L, McKay A, Majeed A. Prevalence of type 2 diabetes in the States of the co-operation council for the Arab States of the Gulf: a systematic review. PLoS ONE. 2012; 7(8):e40948.
- 10Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5): 1047-1053.
- 11 WHO. Diabetes Fact sheet 2015. 2015; http://www.who.int/mediacentre/factsheets/fs312/en/. Accessed 3 April, 2019.
- 12el Bcheraoui C, Basulaiman M, Tuffaha M, et al. Status of the diabetes epidemic in the Kingdom of Saudi Arabia, 2013. Int J Public Health. 2014; 59(6): 1011-1021.
- 13Alqurashi KA, Aljabri KS, Bokhari SA. Prevalence of diabetes mellitus in a Saudi community. Ann Saudi Med. 2011; 31(1): 19-23.
- 14Alzeidan R, Rabiee F, Mandil A, Hersi A, Fayed A. Non-communicable disease risk factors among employees and their families of a Saudi university: an epidemiological study. PLoS ONE. 2016; 11(11):e0165036.
- 15 WorldBank. World Bank health indicators. 2017; https://data.worldbank.org/. Accessed 1 April, 2019.
- 16Lauridsen J, Pradhan J. Socio-economic inequality of immunization coverage in India. Heal Econ Rev. 2011; 1(1): 11.
- 17Doorslaer E, Koolman X. Explaining the differences in income-related health inequalities across European countries. Health Econ. 2004; 13(7): 609-628.
- 18Doorslaer E, Koolman X, Jones AM. Explaining income-related inequalities in doctor utilisation in Europe. Health Econ. 2004; 13(7): 629-647.
- 19Wagstaff A. Doorslaer Ev. Overall versus socioeconomic health inequality: a measurement framework and two empirical illustrations. Health Econ. 2004; 13(3): 297-301.
- 20Bachmann M, Eachus J, Hopper C, et al. Socio-economic inequalities in diabetes complications, control, attitudes and health service use: a cross-sectional study. Diabet Med. 2003; 20(11): 921-929.
- 21Espelt A, Kunst AE, Palencia L, Gnavi R, Borrell C. Twenty years of socio-economic inequalities in type 2 diabetes mellitus prevalence in Spain, 1987–2006. Eur J Pub Health. 2011; 22(6): 765-771.
- 22Hosseinpoor AR, Bergen N, Kunst A, et al. Socioeconomic inequalities in risk factors for non communicable diseases in low-income and middle-income countries: results from the World Health Survey. BMC Public Health. 2012; 12(1): 912.
- 23Espelt A, Borrell C, Palència L, et al. Socioeconomic inequalities in the incidence and prevalence of type 2 diabetes mellitus in Europe. Gac Sanit. 2013; 27(6): 494-501.
- 24De Silva AP, De Silva SHP, Haniffa R, et al. Inequalities in the prevalence of diabetes mellitus and its risk factors in Sri Lanka: a lower middle income country. Int J Equity Health. 2018; 17(1): 45.
- 25Abduljabbar MA, Aljubeh JM, Amalraj A, Cherian MP. Incidence trends of childhood type 1 diabetes in eastern Saudi Arabia. Saudi Med J. 2010; 31(4): 413-418.
- 26Habeb AM, Al-Magamsi MS, Halabi S, Eid IM, Shalaby S, Bakoush O. High incidence of childhood type 1 diabetes in Al-Madinah, North West Saudi Arabia (2004–2009). Pediatr Diabetes. 2011; 12(8): 676-681.
- 27Al-Daghri NM, Al-Attas OS, Alokail MS, et al. Diabetes mellitus type 2 and other chronic non-communicable diseases in the central region, Saudi Arabia (Riyadh cohort 2): a decade of an epidemic. BMC Med. 2011; 9(1): 76.
- 28Al-Baghli N, Al-Ghamdi A, Al-Turki K, Al Elq A, El-Zubaier A, Bahnassy A. Prevalence of diabetes mellitus and impaired fasting glucose levels in the Eastern Province of Saudi Arabia: results of a screening campaign. Singapore Med J. 2010; 51(12): 923.
- 29Moradi-Lakeh M, El Bcheraoui C, Daoud F, et al. Medication use for chronic health conditions among adults in Saudi Arabia: findings from a national household survey. Pharmacoepidemiol Drug Saf. 2016; 25(1): 73-81.
- 30Moradi-Lakeh M, El Bcheraoui C, Afshin A, et al. Diet in Saudi Arabia: findings from a nationally representative survey. Public Health Nutr. 2017; 20(6): 1075-1081.
- 31Al-Saeed AH, Constantino MI, Molyneaux L, et al. An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes. Diabetes Care. 2016; 39(5): 823-829.
- 32Zou W, Ni L, Lu Q, et al. Diabetes onset at 31–45 years of age is associated with an increased risk of diabetic retinopathy in type 2 diabetes. Sci Rep. 2016; 6(1): 38113.
- 33Wagstaff A, Paci P, Van Doorslaer E. On the measurement of inequalities in health. Soc Sci Med. 1991; 33(5): 545-557.
- 34O'donnell O, Van Doorslaer E, Wagstaff A, Lindelow M. Analyzing health equity using household survey data: a guide to techniques and their implementation. The World Bank; 2007.
10.1596/978-0-8213-6933-3 Google Scholar
- 35Erreygers G. Correcting the concentration index. J Health Econ. 2009; 28(2): 504-515.
- 36Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103(2): 137-149.
- 37Meo S, Usmani A, Qalbani E. Prevalence of type 2 diabetes in the Arab world: impact of GDP and energy consumption. Eur Rev Med Pharmacol Sci. 2017; 21(6): 1303-1312.
- 38Thomas NJ, Jones SE, Weedon MN, Shields BM, Oram RA, Hattersley AT. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 2018; 6(2): 122-129.
- 39Cucca F, Goy JV, Kawaguchi Y, et al. A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nat Genet. 1998; 19(3): 301-302.
- 40Al-Rubeaan K, Al-Manaa HA, Khoja TA, et al. Epidemiology of abnormal glucose metabolism in a country facing its epidemic: SAUDI-DM study. J Diabetes. 2015; 7(5): 622-632.
- 41Alwin Robert A, Abdulaziz Al Dawish M, Braham R, Ali Musallam M, Abdullah Al Hayek A, Hazza Al Kahtany N. Type 2 diabetes mellitus in Saudi Arabia: major challenges and possible solutions. Curr Diabetes Rev. 2017; 13(1): 59-64.
- 42Larranaga I, Arteagoitia J, Rodriguez J, et al. Socio-economic inequalities in the prevalence of type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country. Spain Diab Med. 2005; 22(8): 1047-1053.
- 43Espelt A, Borrell C, Roskam A-J, et al. Socioeconomic inequalities in diabetes mellitus across Europe at the beginning of the 21st century. Diabetologia. 2008; 51(11): 1971-1979.
- 44Peykari N, Djalalinia S, Qorbani M, Sobhani S, Farzadfar F, Larijani B. Socioeconomic inequalities and diabetes: a systematic review from Iran. J Diabetes Metab Disord. 2015; 14(1): 8.
- 45Fuller D, Neudorf J, Lockhart S, et al. Individual-and area-level socioeconomic inequalities in diabetes mellitus in Saskatchewan between 2007 and 2012: a cross-sectional analysis. CMAJ Open. 2019; 7(1):E33-E39.
- 46Imkampe AK, Gulliford MC. Increasing socio-economic inequality in type 2 diabetes prevalence—repeated cross-sectional surveys in England 1994–2006. Eur J Pub Health. 2010; 21(4): 484-490.
- 47Hasan M, Tasnim F, Tariqujjaman M, Ahmed S. Socioeconomic inequalities of undiagnosed diabetes in a resource-poor setting: insights from the Cross-Sectional Bangladesh Demographic and Health Survey 2011. Int J Environ Res Public Health. 2019; 16(1): 115.
- 48Mackenbach JP, Stirbu I, Roskam A-JR, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008; 358(23): 2468-2481.
- 49Ricci-Cabello I, Ruiz-Perez I, De Labry-Lima AO, Marquez-Calderon S. Do social inequalities exist in terms of the prevention, diagnosis, treatment, control and monitoring of diabetes? A systematic review. Health Soc Care Community. 2010; 18(6): 572-587.
- 50Al-Hanawi MK, Vaidya K, Alsharqi O, Onwujekwe O. Investigating the willingness to pay for a contributory national health insurance scheme in Saudi Arabia: a cross-sectional stated preference approach. Appl Health Econ Health Policy. 2018; 16(2): 259-271.
- 51Al-Hanawi MK. The healthcare system in Saudi Arabia: how can we best move forward with funding to protect equitable and accessible care for all? Int J Healthcare. 2017; 3(2): 78-94.
10.5430/ijh.v3n2p78 Google Scholar
- 52Buzza C, Ono SS, Turvey C, et al. Distance is relative: unpacking a principal barrier in rural healthcare. J Gen Intern Med. 2011; 26(2): 648-654.
- 53Yamauchi Y, Fujiwara T, Okuyama M. Factors influencing time lag between initial parental concern and first visit to child psychiatric services among ADHD children in Japan. Community Ment Health J. 2015; 51(7): 857-861.
- 54Ward B, Humphreys J, McGrail M, Wakerman J, Chisholm M. Which dimensions of access are most important when rural residents decide to visit a general practitioner for non-emergency care? Aust Health Rev. 2015; 39(2): 121-126.
- 55 MOH. Annual Statistical Book. 2017; http://www.moh.gov.sa/en/Ministry/Statistics/book/Pages/default.aspx. Accessed 27 Sep, 2018.
- 56Al-Hanawi MK, Khan SA, Al-Borie HM. Healthcare human resource development in Saudi Arabia: emerging challenges and opportunities—a critical review. Public Health Rev. 2019; 40(1): 1.
- 57Dong Y, Gao W, Nan H, et al. Prevalence of type 2 diabetes in urban and rural Chinese populations in Qingdao. China Diab Med. 2005; 22(10): 1427-1433.
- 58Chen Z, Roy K. Calculating concentration index with repetitive values of indicators of economic welfare. J Health Econ. 2009; 28(1): 169-175.
- 59Clarke P, Van Ourti T. Calculating the concentration index when income is grouped. J Health Econ. 2010; 29(1): 151-157.
- 60Murugesan N, Snehalatha C, Shobhana R, Roglic G, Ramachandran A. Awareness about diabetes and its complications in the general and diabetic population in a city in southern India. Diabetes Res Clin Pract. 2007; 77(3): 433-437.
- 61Unwin N, Gan D, Whiting D. The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract. 2010; 87(1): 2-3.